Acellular Therapy Market Size, Share, Trends, Growth 2030

Acellular Therapy Industry Prospective:

The global acellular therapy market size was worth around USD 8.451 Billion in 2022 and is predicted to grow to around USD 32.61 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 16.21% between 2023 and 2030.

The report analyzes the global acellular therapy market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the acellular therapy industry.

Request Free Sample

Acellular Therapy Market: Overview

Acellular therapy is an upcoming and breakthrough process in the healthcare sector that makes use of extracellular matrix (ECM) or cellular products that are derived from the cell as opposed to using the entire tissue structure or whole cells. It is a type of medical treatment conducted without the help of a cell as a whole. These therapies include cytokines, growth factors, and other types of bioactive molecules that are derived from the cells and injected into a patient which helps in healing or tissue regeneration. Some examples of acellular therapies include platelet-rich plasma or PRP. In this process, concentrated platelets are harvested from patients' blood and are used to stimulate the healing process.

Key Insights 

• As per the analysis shared by our research analyst, the global acellular therapy market is estimated to grow annually at a CAGR of around 16.21% over the forecast period (2022-2030)
• In terms of revenue, the global acellular therapy market size was valued at around USD 8.451 billion in 2022 and is projected to reach USD 32.61 billion, by 2030.
• The acellular therapy industry is projected to grow at a significant rate due to the growing number of patients with a chronic condition
• Based on scaffold segmentation, extracellular matrix (ECM) was predicted to show maximum market share in the year 2022
• Based on disease segmentation, chronic wounds were the leading disease in 2022
• On the basis of region, North America was the leading revenue generator in 2022

Request Free Sample

To know more about this report, Request a sample copy

Acellular Therapy Market: Growth Drivers

Growing number of patients with chronic conditions to propel market demand

The global acellular therapy market is projected to grow owing to the increasing prevalence of patients suffering from chronic conditions like cardiovascular diseases, diabetes, and cancer. These conditions are currently the leading cause of death. They also impact the overall economic growth of the country. Most of these diseases do not have any cure even with advanced technology and research activities. The healthcare sector can only provide ways of managing the symptoms but cannot help patients get completely rid of the condition. For instance, as per the World Health Organization, there are more than 422 million people who currently live with diabetes across the world and the agency attributes nearly 1.5 million deaths to this medical concern. Due to diabetes, the beta cells in the body of the patient get damaged and hence the person is always susceptible to the disease.

Acellular Therapy Market: Restraints

Regulatory framework limitations to restrict the market growth

Since the medical treatment process is relatively new, most countries lack the necessary regulatory framework required for a complete understanding and adoption of the treatment procedures. Furthermore, there is a significant gap in the availability of supportive infrastructure that can promote the use of acellular therapies. This makes it difficult for the existing global industry players to introduce new products in the market since they are bound to incur roadblocks leading to delays in product development further impacting the final cost of the product. In addition to this, the medical reimbursement policies surrounding acellular therapy are not patient-friendly leading to limited patient databases.

Acellular Therapy Market: Opportunities

Growing technological advancements to provide excellent growth opportunities

The acellular therapy industry is expected to benefit from the rising investments encouraging technological advancements in the field of acellular therapy. The increasing interest can be seen in the addition of new players and government support, technologies like 3-dimensional (3D) bioprinting are expected to help change the sales dynamics for the global market. These new systems are expected to help improve the overall effectiveness of the therapies while ensuring patient safety. Realizing the potential of acellular therapy has allowed many business players to undertake strategic partnerships and collaboration resulting in increased adoption.

Acellular Therapy Market: Challenges

Complex technicalities to challenge market propulsion

Acellular therapies are built on complex procedures and require strict quality measures to ensure the safety and efficacy of the programs. Additionally, there is a lack of knowledge-based among medical professionals regarding the understanding of advanced therapies. This poses a major challenge for the global market since the entire adoption process is based on how informed the medical staff that is working on using acellular therapy as a treatment process is. There cannot be any compromise on the quality measures that determine the safety index of the therapies.

Acellular Therapy Market: Segmentation

The global acellular therapy market is segmented based on disease, application, scaffold, and region

Based on disease, the global market is divided into Parkinson, Alzheimer’s, chronic wounds, sclerosis, and cancer.

• In 2022, the segment was dominated by the chronic wounds section since currently acellular therapies are most significantly used to treat conditions like venous leg ulcers, diabetic foot ulcers, and pressure ulcers
• Chronic wounds are a major area of concern for the medical community as they affect billions of people across the world
• These conditions are known to impact the quality of life of the patient since they have to live with it until the condition cures which can take many years
• Almost 15% of diabetic patients are at risk of contracting diabetic foot ulcer

Based on application, the acellular therapy industry segments are hepatology, cardiology, neurology, oncology, and gastroenterology.

Based on scaffold. The global market is segmented into fused deposition modeling (FDM), cell laden hydrogel, extracellular matrix (ECM), and selective laser sintering (SLS)

• The choice of scaffold is dependent on the type of harvested tissue along with the expected or desired properties of the tissue including bioactivity, biocompatibility, and mechanical strength
• The most used scaffold as of 2022 is the extracellular matrix (ECM). It is a mixture of protein and other molecules and is extremely complex. It is required to provide biochemical signals and structural support to existing cells inside a tissue.
• They are popular since they offer various advantages over counterparts including rapid tissue regeneration and the capability to be customized for specific results
• A recent clinical study concluded that the healing rate of treating chronic wounds with acellular therapy was around 66.3%

Recent Developments:

• In August 2021, Organogenesis Holdings Inc., a dominating regenerative medicine company, announced Medicare will be providing the company’s PuraPly product with a fresh set of investments. The product is a highly advanced device made using an acellular dermal matrix and is used for wound care. The investment will encourage product adoption in the commercial market
• In March 2021, Osiris Therapeutics, an important player in the global industry, announced that Smith and Nephew completed its acquisition for USD 660 million. The move will help the latter strengthen its hold in the acellular therapy segment
• In July 2021, a research study published in the Journal of Tissue Engineering and Regenerative Medicine concluded that the acellular dermal matrix (ADM) is useful in repairing rotator cuff tears

Acellular Therapy Market Report Scope:

Acellular Therapy Market: Regional Analysis

North America to continue its dominance over the market

The global acellular therapy market is anticipated to register the highest growth in North America. The high CAGR is driven by the extensive knowledge of the treatment methodology along with supporting infrastructure. The US is home to one of the most technically advanced medical communities which is far ahead in terms of research and medicine availability as compared to other parts of the world. Furthermore, the growing interest of the healthcare sector in exploring more areas around the applications of acellular therapy has opened the door for millions in investment to encourage researchers.

The regional growth is dependent on the high number of chronic illnesses reported in the country and patient awareness about the different treatment options available. Favorable medical reimbursements allow more people to opt for high-cost treatment which is generally not observed in struggling economies.

Acellular Therapy Market: Competitive Analysis

The global acellular therapy market is led by players like:

• Codiak BioSciences Ltd.
• Evox Therapeutics Ltd.
• Stem Cell Medicine Ltd.
• Capricor Therapeutics
• Exogenous Therapeutics
• Organicell Regenerative Medicine Inc.
• Aegle Therapeutics Corp
• ArunA Biomedical
• Rion LLC.
• Invitrx Therapeutics Inc.
• Direct Biologics LLC.
• Stem Cell Medicine Ltd.

The global acellular therapy market is segmented as follows:

By Disease

• Parkinson’s
• Alzeihmer’s
• Chronic Wounds
• Sclerosis
• Cancer

By Application

• Hepatology
• Orthopedic
• Cardiology
• Neurology
• Oncology
• Gastroenterology

By Scaffold

• Fused Deposition Modeling (FDM)
• Cell Laden Hydrogel
• Extracellular Matrix (ECM)
• Selective Laser Sintering (SLS)

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa